SARS-CoV-2 ORF3a Alexa Fluor® 647-conjugated Antibody

Catalog #: FAB107061R Datasheet / COA / SDS

Recombinant Monoclonal Antibody

Catalog #	Availability	Size / Price	Qty
FAB107061R-100UG

Save 15% on Select RUO Reagents. See Details.

All ORF3a Antibodies

Product Details

Supplemental Products

Reviews

Summary Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

SARS-CoV-2 ORF3a Alexa Fluor® 647-conjugated Antibody Summary

Species Reactivity

SARS-CoV-2

Specificity

Detects SARS-CoV-2 ORF3a in Western blots.

Source

Monoclonal Rabbit IgG Clone # 2819D

Purification

Protein A or G purified

Immunogen

SARS-CoV-2 ORF3a peptide

Formulation

Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Label

Alexa Fluor 647 (Excitation= 650 nm, Emission= 668 nm)

Applications

Recommended Concentration

Sample

Western Blot

Optimal dilution of this antibody should be experimentally determined.

Immunohistochemistry

Optimal dilution of this antibody should be experimentally determined.

Immunocytochemistry

Optimal dilution of this antibody should be experimentally determined.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Reconstitution Calculator

Preparation and Storage

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied

Background: ORF3a

ORF3a is an open reading frame coronavirus protein involved in virus replication in release. Analysis of ORF3a nucleotide and protein sequences can predict their ability to alter viral cycle and provides insight into the biology of coronaviruses. ORF3a has been characterized in both SARS-CoV which caused the SARS outbreak and in SARS-CoV-2 which caused the COVID-19 pandemic. ORF3a is a high priority target that is amenable to drug treatment for COVID-19 post viral syndrome. Mutations in ORF3a can help understand viral virulence and design suitable therapeutics.

Long Name

ORF3a

Entrez Gene IDs

43740569 (SARS-CoV-2)

Alternate Names

ORF3a; U274; X1